
| Serial Number | 86698323 |
| Word Mark | MICROBAC |
| Filing Date | Monday, July 20, 2015 |
| Status | 701 - SECTION 8 - ACCEPTED |
| Status Date | Monday, July 3, 2023 |
| Registration Number | 4986679 |
| Registration Date | Tuesday, June 28, 2016 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 12, 2016 |
| Certificate of Correction for Registration | In the statement, line 19, "containing microorganisms and cultures of microorganisms" should be should be inserted after "products". |
| Goods and Services | Micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; Pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, including, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; Microbial and biological preparations for improving the physical well-being of humans, namely, reducing inflammation and pain; Supplements, namely, dietary supplements, for medical use and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; Supplements, namely, dietary supplements for medical use and baby food, all the above containing liquid, solid, dried or freeze-dried microorganisms or concentrated cultures of probiotic microorganisms; ferments for medical purposes, all the foregoing being for medical and veterinary use only |
| Pseudo Mark | MICRO BACK |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 24, 2015 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | PROBIOTICAL S.P.A. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | Novara (NO) 28100 IT |
| Party Name | PROBIOTICAL S.P.A. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | 28100 NOVARA IT |
| Party Name | PROBIOTICAL S.P.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | 28100 NOVARA IT |
| Event Date | Event Description |
| Wednesday, January 13, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 26, 2016 | ASSIGNED TO LIE |
| Thursday, January 28, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 28, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 2, 2016 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, July 23, 2015 | NEW APPLICATION ENTERED |
| Friday, July 24, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, July 25, 2015 | NOTICE OF PSEUDO MARK E-MAILED |
| Thursday, October 29, 2015 | ASSIGNED TO EXAMINER |
| Friday, October 30, 2015 | NON-FINAL ACTION WRITTEN |
| Friday, October 30, 2015 | NON-FINAL ACTION E-MAILED |
| Friday, October 30, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 2, 2016 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 2, 2016 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, March 2, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 2, 2016 | ASSIGNED TO LIE |
| Tuesday, April 12, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 2, 2016 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 9, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, March 23, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, August 1, 2016 | SEC 7 REQUEST FILED |
| Tuesday, December 27, 2022 | TEAS SECTION 8 RECEIVED |
| Tuesday, April 12, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 28, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Monday, August 1, 2016 | PAPER RECEIVED |
| Monday, October 31, 2016 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, October 31, 2016 | CORRECTION UNDER SECTION 7 - PROCESSED |
| Monday, June 28, 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, February 7, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, February 7, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, December 10, 2024 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| Tuesday, February 7, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, June 20, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, July 3, 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| Monday, July 3, 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| Tuesday, December 10, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, December 10, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, December 10, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, December 10, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, December 10, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, December 10, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, July 8, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, July 8, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, July 8, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, July 8, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, July 8, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Saturday, June 28, 2025 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |